- Covered insulin costs at most $35/month per product under Part D in 2026, and no deductible applies to insulin.
- The insulin must be on your plan's formulary; syringes, pumps, and other supplies are not part of the cap.
- Your $35 insulin copays count toward the $2,100 annual out-of-pocket cap, after which covered drugs are $0.
If you take insulin and you have Medicare drug coverage, you may have heard that nobody should pay more than $35 a month for it. That is true — with a few important conditions. Thanks to the Inflation Reduction Act (in effect since 2023 and solidified in CMS's 2026 final rule), any covered insulin product costs at most $35 for a one-month supply under Medicare Part D, with no deductible in the way.
The $35 cap, in plain English
Every Medicare prescription drug plan — stand-alone Part D plans and Medicare Advantage plans with drug coverage — must cap your cost for a one-month supply of each covered insulin product at $35, through every phase of Part D coverage: deductible, initial coverage, and catastrophic. The cap never disappears mid-year.
- Per product, per month. Two different insulins (say, a basal insulin plus a mealtime insulin) means up to $35 for each — not $35 total.
- A 90-day mail-order fill is capped at three months' worth: typically no more than $105.
- No deductible on insulin. Standard plans make you pay full cost up to the yearly deductible (up to $615 in 2026). Insulin skips that step — the cap applies from your first fill of the year.
- Automatic. No application, sign-up, or waiver. The plan prices the claim this way by rule, and if its normal copay is already below $35, you pay the lower amount.
Which insulin products qualify
The cap covers covered insulin products — insulin types that appear on your plan's formulary. Plans must honor the cap regardless of tier, even a high specialty tier. That includes rapid-acting (lispro, aspart, glulisine), short-acting (regular), long-acting basal (glargine, detemir, degludec), intermediate (NPH), premixed (70/30), and inhaled insulin — if the product is on your plan's formulary.
That "if" is the critical qualifier. Formularies differ from plan to plan: an insulin capped at $35 on one plan might not be covered at all on another. During Annual Enrollment (October 15 – December 7), the most valuable step you can take is entering your exact insulin products into the Medicare Plan Finder and confirming each is on the plan's formulary for next year.
What the $35 cap does not cover
- Diabetic supplies. Syringes, needles, pen needles, and alcohol swabs are not insulin — they carry their own cost-sharing, not the $35 cap.
- Insulin not on your formulary. Full price unless you win a formulary exception (a formal request, with your prescriber's support, that the plan cover the drug).
- Non-insulin diabetes drugs. Metformin or GLP-1s prescribed for diabetes (such as Ozempic or Mounjaro) have their own tier pricing — no $35 cap.
- Insulin billed outside your Part D benefit. If a pharmacy runs the prescription through a discount card like GoodRx instead of your Part D plan, the cap does not apply — and those dollars do not count toward your Part D out-of-pocket cap.
Pump users, note: insulin delivered through a non-disposable pump covered as durable medical equipment falls under Part B, where it is also capped at $35 per month per product with no Part B deductible. Same idea, different part of Medicare.
How it fits with the $2,100 out-of-pocket cap
Separate from the insulin rule, Part D caps your total out-of-pocket spending on covered drugs at $2,100 in 2026 — after that, you pay $0 for covered drugs for the rest of the year. Your $35 insulin payments count toward that $2,100. And the Medicare Prescription Payment Plan lets you spread out-of-pocket costs into predictable monthly payments if other drugs are pushing you toward the cap early in the year.
If you are charged more than $35
- Is the insulin on your plan's formulary? If not, ask your doctor about a covered alternative, or request a formulary exception.
- Check the days' supply. A 60- or 90-day fill is capped proportionally — more than $35, but no more than $35 per month.
- Was it billed to your Part D plan? A discount card or cash price bypasses your coverage and the cap.
- Call your plan. Processing errors happen — the member-services number on your plan ID card can reprocess the claim.
Bottom line: In 2026, every insulin product on your Part D plan's formulary costs at most $35 per month — no deductible, in every coverage phase — so verify your insulin is on the formulary during open enrollment and never quietly pay more at the counter.